Purple Biotech director reports initial holdings
PURPLE BIOTECH LTD. director Suzana Zilberberg filed an initial ownership report showing her equity stake in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
PURPLE BIOTECH LTD. director Suzana Zilberberg filed an initial ownership report showing her equity stake in the company. She directly holds 3,062,500 Ordinary Shares as of the reported date, including 2,454,167 unvested restricted stock units that will settle in Ordinary Shares.
She also holds stock options to purchase 112,500 Ordinary Shares at $0.126875 per share expiring on December 29, 2026, options for 300,000 Ordinary Shares at $0.059375 per share expiring on April 24, 2028, and options for 2,650,000 Ordinary Shares at $0.00309375 per share expiring on October 21, 2030, with portions of these options vesting over time.
Insider Trade Summary
4 transactions reported
Mixed
4 txns
Insider
Zilberberg Suzana
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 3,062,500 contracts (Direct);
Ordinary Shares — 3,062,500 shares (Direct)
Footnotes (4)
- F1. Includes 2,454,167 unvested restricted stock units ("RSUs"), each with respect to one ordinary share, no par value, per share ("Ordinary Shares"), of Purple Biotech Ltd. (the "Issuer"). The RSUs are subject to time-based vesting conditions and are settled in Ordinary Shares. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares
- F2. Represents stock option to purchase 112,500 Ordinary Shares (equivalent to 150 ADSs), issued to the reporting person pursuant to the Issuer's 2016 Equity-Based Incentive Plan. The stock option is fully vested and exercisable. The exercise price of this stock option is $0.126875 per Ordinary Share and the option expires on December 29, 2026.
- F3. Represents stock option to purchase 300,000 Ordinary Shares (equivalent to 150 ADSs), issued to the reporting person pursuant to the Issuer's 2016 Equity-Based Incentive Plan. Options to purchase 274,997 Ordinary Shares are vested and exercisable, with the remaining options to purchase 25,003 Ordinary Shares vesting in equal quarterly installments until April 24, 2026. The exercise price of this stock option is $0.059375 per Ordinary Share and the option expires on April 24, 2028.
- F4. Represents stock option to purchase 2,650,000 Ordinary Shares (equivalent to 1,325 ADSs), issued to the reporting person pursuant to the Issuer's 2016 Equity-Based Incentive Plan. Options to purchase 220,833 Ordinary Shares are vested and exercisable, with the remaining options to purchase 2,429,167 Ordinary Shares vesting in equal quarterly installments until October 21, 2028. The exercise price of this stock option is $0.00309375 per Ordinary Share and the option expires on October 21, 2030.
Key Figures
Ordinary Shares held: 3,062,500 Ordinary Shares
Unvested RSUs: 2,454,167 RSUs
Option grant 1 size: 112,500 Ordinary Shares
+5 more
8 metrics
Ordinary Shares held
3,062,500 Ordinary Shares
Direct holdings as of transaction date
Unvested RSUs
2,454,167 RSUs
Each RSU for one Ordinary Share, time-based vesting
Option grant 1 size
112,500 Ordinary Shares
Fully vested stock option, expires December 29, 2026
Option grant 1 exercise price
$0.126875 per Ordinary Share
Exercise price for 112,500-share option
Option grant 2 size
300,000 Ordinary Shares
Partially vested, fully vests by April 24, 2026
Option grant 2 exercise price
$0.059375 per Ordinary Share
Exercise price for 300,000-share option
Option grant 3 size
2,650,000 Ordinary Shares
Partially vested, fully vests by October 21, 2028
Option grant 3 exercise price
$0.00309375 per Ordinary Share
Exercise price for 2,650,000-share option
Key Terms
restricted stock units, American Depositary Shares, exercise price, time-based vesting conditions, +1 more
5 terms
restricted stock units financial
"Includes 2,454,167 unvested restricted stock units ("RSUs"), each with respect to one ordinary share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
exercise price financial
"The exercise price of this stock option is $0.126875 per Ordinary Share and the option expires"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
time-based vesting conditions financial
"The RSUs are subject to time-based vesting conditions and are settled in Ordinary Shares."
Equity-Based Incentive Plan financial
"issued to the reporting person pursuant to the Issuer's 2016 Equity-Based Incentive Plan."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Purple Biotech (PPBT) Form 3 filing by Suzana Zilberberg show?
The Form 3 filing shows director Suzana Zilberberg’s initial ownership in Purple Biotech. She reports direct holdings of Ordinary Shares, a large block of unvested RSUs, and several stock option grants with specified exercise prices and expiration dates.
What restricted stock units (RSUs) are disclosed for Suzana Zilberberg in PPBT?
She holds 2,454,167 unvested RSUs, each representing one Ordinary Share of Purple Biotech. These RSUs are subject to time-based vesting and are settled in Ordinary Shares, which may be represented by American Depositary Shares according to the disclosure.
What stock option grants does Suzana Zilberberg have in Purple Biotech (PPBT)?
She holds three stock option grants: 112,500 shares at $0.126875, 300,000 shares at $0.059375, and 2,650,000 shares at $0.00309375 per Ordinary Share, each with different vesting schedules and expiration dates extending to October 21, 2030.
Are Suzana Zilberberg’s stock options in PPBT fully vested?
One grant for 112,500 Ordinary Shares is fully vested. For the 300,000-share grant, 274,997 are vested, with 25,003 vesting quarterly until April 24, 2026. For the 2,650,000-share grant, 220,833 are vested, with the rest vesting quarterly until October 21, 2028.
AI-generated analysis. How Rhea-AI works. Not financial advice.
